Effect of Oral Probiotic Yeast on the Composition of the Vaginal Microbiota in Healthy Women

NCT03574844 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-05-21

No results posted yet for this study

Summary

This study is designed to evaluate the impact of oral consumption of the probiotic yeast CNCM I-3856 on healthy vaginal microbiota

Conditions

  • Vaginal Health

Interventions

DIETARY_SUPPLEMENT

Saccharomyces cerevisiae, dose 500

Experimental arm

DIETARY_SUPPLEMENT

Saccharomyces cerevisiae, dose 1000

Experimental arm

DIETARY_SUPPLEMENT

Placebo

Placebo comparator arm

Sponsors & Collaborators

  • Biofortis Mérieux Nutriscience

    collaborator UNKNOWN
  • Lesaffre International

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2019-01-15
Completion
2019-02-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03574844 on ClinicalTrials.gov